Details of the Drug

General Information of Drug (ID: DM97APK)

Drug Name
RG6264
Indication
Disease Entry ICD 11 Status REF
HER2-positive breast cancer 2C60-2C65 Phase 1 [1]
Cross-matching ID
TTD ID
D0LZ7Z

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)